English

Eligibility Obesity NCT00478972

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Obesity NCT00478972
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus patients inadequately treated with diet and exercise alone (not drug treated)
Description

Non-Insulin-Dependent Diabetes Mellitus Treated Inadequate | Diet therapy | Exercise therapy | Pharmacotherapy Lacking

Data type

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C1522326
UMLS CUI [1,3]
C0205412
UMLS CUI [2]
C0012159
UMLS CUI [3]
C0452240
UMLS CUI [4,1]
C0013216
UMLS CUI [4,2]
C0332268
hba1c ≥ 7.0 % and ≤ 10.0 %
Description

Glycosylated hemoglobin A

Data type

boolean

Alias
UMLS CUI [1]
C0019018
body mass index ≥ 25 kg/m²
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes
Description

Diabetes Mellitus, Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011854
within 12 weeks prior to screening visit: use of oral antidiabetic drugs and/or insulin, of anti-obesity drugs or other drugs for weight reduction
Description

Antidiabetics Oral | Insulin | Anti-Obesity Agents | Weight-Loss Agents

Data type

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [2]
C0021641
UMLS CUI [3]
C0376607
UMLS CUI [4]
C0376606
within 4 weeks prior to screening visit: administration of systemic long-acting corticosteroids or prolonged use (more than one week) of other systemic corticosteroids, change in lipid lowering treatment
Description

CORTICOSTEROIDS FOR SYSTEMIC USE Active Long-term | CORTICOSTEROIDS FOR SYSTEMIC USE Intake Prolonged | Lipid-lowering therapy Change

Data type

boolean

Alias
UMLS CUI [1,1]
C3653708
UMLS CUI [1,2]
C0205177
UMLS CUI [1,3]
C0443252
UMLS CUI [2,1]
C3653708
UMLS CUI [2,2]
C1512806
UMLS CUI [2,3]
C0439590
UMLS CUI [3,1]
C0585943
UMLS CUI [3,2]
C0392747
secondary obesity
Description

secondary obesity

Data type

boolean

Alias
UMLS CUI [1]
C2062945
primary hyperlipidemia
Description

Hyperlipidemia Primary

Data type

boolean

Alias
UMLS CUI [1,1]
C0020473
UMLS CUI [1,2]
C0205225
positive serum pregnancy test in females of childbearing potential
Description

Childbearing Potential Serum pregnancy test positive

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0430063
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
Back to the top of the page

Similar models

Eligibility Obesity NCT00478972

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Obesity NCT00478972
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus Treated Inadequate | Diet therapy | Exercise therapy | Pharmacotherapy Lacking
Item
type 2 diabetes mellitus patients inadequately treated with diet and exercise alone (not drug treated)
boolean
C0011860 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C0012159 (UMLS CUI [2])
C0452240 (UMLS CUI [3])
C0013216 (UMLS CUI [4,1])
C0332268 (UMLS CUI [4,2])
Glycosylated hemoglobin A
Item
hba1c ≥ 7.0 % and ≤ 10.0 %
boolean
C0019018 (UMLS CUI [1])
Body mass index
Item
body mass index ≥ 25 kg/m²
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Antidiabetics Oral | Insulin | Anti-Obesity Agents | Weight-Loss Agents
Item
within 12 weeks prior to screening visit: use of oral antidiabetic drugs and/or insulin, of anti-obesity drugs or other drugs for weight reduction
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2])
C0376607 (UMLS CUI [3])
C0376606 (UMLS CUI [4])
CORTICOSTEROIDS FOR SYSTEMIC USE Active Long-term | CORTICOSTEROIDS FOR SYSTEMIC USE Intake Prolonged | Lipid-lowering therapy Change
Item
within 4 weeks prior to screening visit: administration of systemic long-acting corticosteroids or prolonged use (more than one week) of other systemic corticosteroids, change in lipid lowering treatment
boolean
C3653708 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
C0443252 (UMLS CUI [1,3])
C3653708 (UMLS CUI [2,1])
C1512806 (UMLS CUI [2,2])
C0439590 (UMLS CUI [2,3])
C0585943 (UMLS CUI [3,1])
C0392747 (UMLS CUI [3,2])
secondary obesity
Item
secondary obesity
boolean
C2062945 (UMLS CUI [1])
Hyperlipidemia Primary
Item
primary hyperlipidemia
boolean
C0020473 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
Childbearing Potential Serum pregnancy test positive
Item
positive serum pregnancy test in females of childbearing potential
boolean
C3831118 (UMLS CUI [1,1])
C0430063 (UMLS CUI [1,2])
Study Subject Participation Status
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1])
Back to the top of the page